Seventeenth Fellows Forum on Osteoporosis and Metabolic Bone Diseases
October 11-12, 2023 in Vancouver, British Columbia, Canada
Accepting Applications through June 15
The Sixteenth Fellows Forum on Metabolic Bone Diseases, was held at the JW Marriot Austin Downtown on September 7-8 prior to the ASBMR Annual Meeting, which was held on September 9-12, 2022.
Faculty included a distinguished group of leaders including Drs. Clifford Rosen, Ego Seeman, John, P. Bilezikian, Susan Bukata, Mary Bouxsein, Michael McClung, Paul Miller, Michael Whyte, Bart Clarke, Teresita Bellido, Deborah Sellmeyer, Neil Binkley and Kristy Nicks. The topics presented and discussed were timely and among the most important in our field.
Each year the program is comprised of plenary lectures, breakout workshops, and a poster session. Fellows present their work in one of two poster sessions where they receive faculty and peer feedback. We view the poster session as one of the highlights of the day and look forward to hearing about fellows’ exciting research in this setting. The 2022 Fellows rose to the occasion and did a great job.
Poster Session
International Connections
The 2022 Forum was attended by fellows from across the United Sates and eight other countries. We were thrilled to welcome Roksolana to the program this year and we applaud her dedication to continuing her education. Roksolana traveled to the Forum from Kyiv, Ukraine; a long trip indeed. Roksolana, her colleagues, and countrymen remain in our thoughts.
Attending Both the Fellows Forum and the ASBMR Annual Meeting
- To derive the greatest benefit from this formative experience, fellows are expected to participate in both the Fellows Forum and the ASBMR Annual Meeting. Fellows participating in the EFF-ASBMR Forum and ASBMR Annual Meeting will also receive:
- 1-year free ASBMR membership starting in January 2023
- Heavily discounted registration fee for the ASBMR Annual Meeting
Educational Support
This educational activity is supported by unrestricted educational grants from: Amgen, Amolyt Pharma, the National Institutes of Health*, Radius, and the American Society for Bone and Mineral Research (ASBMR).
*Funding for this conference was made possible (in part) by 1R13AR081667-01 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and all co-funding support provided by National Institute On Aging (NIA). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government."